Ten newArizona serotypes isolated from animals and animal food products

Summary Ten hitherto unrecognizedArizona serotype (1, 2:13, 14; 5:1, 7, 8; 9:17, 20; 9:29:31; 10:1, 7, 8; 17:1, 2, 5, 6; 20:13, 14; 20:23, 30; 26:26:25, and 30:23:25) are described. The organisms were isolated from fowls, a kangaroo rat, a lizard, various species of snakes, and Indian crushed bone.     

Current status of regulating biotechnology-derived animals in Canada: animal health and food safety considerations

Development of an effective regulatory system for genetically engineered animals and their products has been the subject of increasing discussion among researchers, industry and policy developers, as well as the public. Since transgenesis and cloning are relatively new scientific techniques, transgenic animals are 'novel' organisms for which there is limited information. The issues associated with the regulation of transgenic animals pertain to environmental impact, human food safety, animal health and welfare, trade and ethics. It is a challenge for the developers to prove the safety of the products of biotechnology-derived animals and also for regulators to regulate this increasingly powerful technology with limited background information. In principle, an effective regulatory sieve should permit safe products while forming a formidable barrier for those posing an unacceptable risk. Regulatory initiatives for biotechnology-derived animals and their products should be able to ensure high standards for human and animal health, a sound scientific basis for evaluation; transparency and public involvement, and maintenance of genetic diversity. This review proposes a regulatory regime that is based on scientific risk based assessment and approval of products or by-products of biotechnology-derived animals and its application in context to Canadian regulations.     

Improvement of selection indices for animals]

Selection indices should be used taking into account their correlations with the selected characters. The method of relative values to determine selection indices gives a more reliable evaluation of boars.     

Genomics for food safety and sustainable animal production

There is a growing concern in society about the safety of animal-derived food, the health and welfare of farm animals and the sustainability of current animal production systems. Along farm animal, breeding genomics may contribute to a solution for these concerns. The use of genomic analysis tools, to achieve genetic progress in typical out-bred populations of farm animals, seems to be more difficult compared to 'model' organisms or plants. However, identification of positional candidate genes may be accelerated by linkage disequilibrium (LD) mapping. Recording of sustainable traits requires a large financial and logistic input and the economic advantages for the market are not as clear as for traditional selection traits. Examples show that the major genes causing variability for similar traits in different species are rarely the same. Therefore, for breeding purposes genomic analysis of the species of interest is needed. The fundamental knowledge obtained on the genetic architecture of complex traits will open new perspectives for the use of DNA tests in selection schemes. For food safety and traceability, DNA-based techniques evolve for monitoring and early warning systems.     

Genetic modification of food animals

1. Download : Download high-res image (332KB)
2. Download : Download full-size image

     

Evaluation of a fluorescent antibody-enrichment serology combination procedure for the detection of salmonellae in condiments, food products, food by-products, and animal feeds

[This corrects the article on p. 751 in vol. 25.].     

Identity, traceability, acceptability and substantial equivalence of food.

The numerous food crises that Europe has experienced during the past five years have raised new consumer demands concerning the characterization, traceability, and safety of foods which are proposed on the market. The consumer has, at the same time, vigorously placed into question the modes of agricultural production in industrialized countries, as well as the structures and means of evaluating the food risks and the conditions of the consumer's participation in the public debate in these domains. For certain groups of consumers, one also attends a contestation of the expertise and the application to the food domain of the considerable progress that has taken place in the field of biotechnology. So it is that the development of genetically modified organisms (mainly plants, the raw material of food products) has experienced a slowing down in the European Union. The answers afforded to these new exigencies of consumers in matter of identity, traceability, and acceptability of the foods are dealt with in this paper, as well as the elements which may concur with the evaluation of their safety. The positive role that biotechnology can afford to the different domains is emphasized. A source of uneasiness, biotechnology is also a powerful tool for ameliorating the evaluation of the sanitary risks and for answering the hopes of the citizen in the food domain.     

模式动物与人类疾病的动物模型

围绕疾病所开展的基础研究已成为当今生物医学研究领域中的主要内容,而利用模式动物建立疾病的动物模型已是其研究的重要手段,对疾病的基础研究和转化研究均具有重要意义,已成为影响该领域发展的一个关键因素。我国医学研究领域中加强人类疾病动物模型研究既是一个现实问题,更是一个迫切问题,国家自然科学基金委员会医学科学部将在这方面予以倾斜支持。     

Bioinformatic challenges for DNA metabarcoding of plants and animals

Almost all empirical studies in ecology have to identify the species involved in the ecological process under examination. DNA metabarcoding, which couples the principles of DNA barcoding with next generation sequencing technology, provides an opportunity to easily produce large amounts of data on biodiversity. Microbiologists have long used metabarcoding approaches, but use of this technique in the assessment of biodiversity in plant and animal communities is under-explored. Despite its relationship with DNA barcoding, several unique features of DNA metabarcoding justify the development of specific data analysis methodologies. In this review, we describe the bioinformatics tools available for DNA metabarcoding of plants and animals, and we revisit others developed for DNA barcoding or microbial metabarcoding. We also discuss the principles and associated tools for evaluating and comparing DNA barcodes in the context of DNA metabarcoding, for designing new custom-made barcodes adapted to specific ecological question, for dealing with PCR and sequencing errors, and for inferring taxonomical data from sequences.     

Use of antibiotics in food animals

The authors present in this paper a review on a major problem which is less evoked in Tunisia and concerns the use of antibiotics in Veterinary Medicine for reared animals for human consumption. Antibiotics are often mis used; this is true for the practitioner as well as for the breeder. The rules of antibiotic associations and their related problems are also discussed. Specific recommendations to Tunisian users are suggested; the pharmaceutical industry, the veterinarian and the breeder. Each from its side must contribute to the preservation of this valuable therapeutic tool.     

Bacteriophage biocontrol in animals and meat products

Since their discovery almost a century ago, bacterial viruses (bacteriophages or ‘phages’) have been used to prevent and treat a multitude of bacterial infections (phage therapy: PT). In addition, they have been the basis for many advances in genetics and biochemistry. Phage therapy was performed on human subjects in the United States, Europe and Asia in the few decades following their discovery. However, Western countries largely abandoned PT in favour of antibiotics in the 1940s. The relatively recent renaissance of PT in the West can be attributed partly to the increasing prevalence of antibiotic resistance in human and animal pathogens. However, the stringent controls on human trials now required in the United States and Europe have led to a greater number of domestic animal and agricultural applications as an alternative to PT in man. This trend is set to continue, at least in the short term, with recent approval from the Food and Drug Administration allowing commercial phage treatments to be used in human food in the USA. Nevertheless, despite these significant milestones and the growing number of successful PT trials, significant obstacles remain to their widespread use in animals, food and ultimately medicine in many parts of the world. This review will provide a brief overview of the history of PT in the West and will summarize some of the key findings of phage biocontrol studies in animals and meat products.     

Nutritive fibers of animal origin. Collagen and its fractions as essential components of new and efficient food products

Data on the production of collagen and its fractions (which in many cases surpass the parent protein in functional properties), reported in the literature throughout the past two decades, are reviewed. The material presented elucidates the role played by collagen and its fractions in the development of new, ecologically pure foodstuffs containing nutritive fibers. As follows from the analysis of the data, collagen fractions with molecular weights in excess of 120 kDa offer the greatest promise for producing useful foodstuffs.     

Integrated production and distribution planning for perishable food products

Certain types of food, such as catering foods, decay very rapidly. This paper investigates how the quality of such foods can be improved by shortening the time interval between production and delivery. To this end, we develop an approach that integrates short-term production and distribution planning in an iterative scheme. Further, an aggregation scheme is developed as the interface between the production scheduling and distribution problem. The production scheduling problem is solved through an MILP modeling approach which is based on a block planning formulation. Our implementation shows promising results, elaborated in a numerical investigation, which recollects the real settings of a catering company located in Denmark.     

An overview of animal cell substrates for biological products

The issue of which cells to use as substrates for the production of biological products, and especially vaccines, has been with us in one form or another ever since the development of cell cultures in the 1950s.The major cell substrate events that occurred over the past 50 years are reviewed briefly. Although numerous conferences were held during that period, incomplete resolution of some cell substrate issues has remained. Specifically, the potential oncogenicity of cellular DNA derived from continuous cell lines, and the tests that are used to rule out the presence of adventitious agents have been recognized as areas that could benefit greatly from studies using state-of-the-art techniques.A collaborative effort involving WHO, NIAID, and IABS resulted from consensus recommendations of a 2004 conference, and the prospects for revised guidance in the near future on the characterization and use of animal cell substrates are bright.